NO960393D0 - Heterosykliske fenylforbindelser som COX-2-inhibitorer - Google Patents
Heterosykliske fenylforbindelser som COX-2-inhibitorerInfo
- Publication number
- NO960393D0 NO960393D0 NO960393A NO960393A NO960393D0 NO 960393 D0 NO960393 D0 NO 960393D0 NO 960393 A NO960393 A NO 960393A NO 960393 A NO960393 A NO 960393A NO 960393 D0 NO960393 D0 NO 960393D0
- Authority
- NO
- Norway
- Prior art keywords
- cox
- inhibitors
- phenyl compounds
- heterocyclic phenyl
- heterocyclic
- Prior art date
Links
- 229940111134 coxibs Drugs 0.000 title 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
- C07C311/46—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
- C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/179,467 US5474995A (en) | 1993-06-24 | 1994-01-10 | Phenyl heterocycles as cox-2 inhibitors |
| PCT/CA1994/000688 WO1995018799A1 (en) | 1994-01-10 | 1994-12-19 | Phenyl heterocycles as cox-2 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO960393D0 true NO960393D0 (no) | 1996-01-30 |
| NO960393L NO960393L (no) | 1996-07-09 |
Family
ID=22656713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO960393A NO960393L (no) | 1994-01-10 | 1996-01-30 | Heterosykliske fenylforbindelser som COX-2-inhibitorer |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0739340A1 (no) |
| JP (1) | JP2788677B2 (no) |
| CN (1) | CN1143365A (no) |
| AU (1) | AU1269495A (no) |
| BG (1) | BG63082B1 (no) |
| BR (1) | BR9408478A (no) |
| CA (1) | CA2180651A1 (no) |
| FI (1) | FI108792B (no) |
| HU (1) | HUT74986A (no) |
| NO (1) | NO960393L (no) |
| SG (1) | SG43841A1 (no) |
| WO (1) | WO1995018799A1 (no) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9420616D0 (en) * | 1994-10-12 | 1994-11-30 | Merck Sharp & Dohme | Method, compositions and use |
| AU715676B2 (en) * | 1993-03-12 | 2000-02-10 | Merck Frosst Canada & Co. | Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5840746A (en) * | 1993-06-24 | 1998-11-24 | Merck Frosst Canada, Inc. | Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
| US5585504A (en) * | 1994-09-16 | 1996-12-17 | Merck & Co., Inc. | Process of making cox-2 inhibitors having a lactone bridge |
| US6593361B2 (en) | 1995-07-19 | 2003-07-15 | Merck & Co Inc | Method of treating colonic adenomas |
| DE69632632T2 (de) * | 1995-07-19 | 2005-05-25 | Merck & Co., Inc. | Behandlungsverfahren für darmadenome |
| US5968974A (en) | 1995-07-19 | 1999-10-19 | Merck & Co., Inc. | Method of treating colonic adenomas |
| AU775030B2 (en) * | 1996-05-17 | 2004-07-15 | Merck Frosst Company | Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases |
| KR100373622B1 (ko) * | 1996-05-17 | 2003-07-12 | 머크 앤드 캄파니 인코포레이티드 | 사이클로옥시게나제-2로매개된질환의1일1회치료용조성물 |
| GB9615867D0 (en) * | 1996-07-03 | 1996-09-11 | Merck & Co Inc | Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
| US5939069A (en) * | 1996-08-23 | 1999-08-17 | University Of Florida | Materials and methods for detection and treatment of immune system dysfunctions |
| EP0975604B1 (en) * | 1997-03-14 | 2004-07-21 | Merck Frosst Canada & Co. | Pyridazinones as inhibitors of cyclooxygenase-2 |
| US6004960A (en) * | 1997-03-14 | 1999-12-21 | Merck Frosst Canada, Inc. | Pyridazinones as inhibitors of cyclooxygenase-2 |
| US6136831A (en) * | 1997-04-11 | 2000-10-24 | Grelan Pharmaceutical Co., Ltd. | Pyrazole derivatives and COX inhibitors containing them |
| WO1998051667A1 (en) * | 1997-05-16 | 1998-11-19 | Chugai Seiyaku Kabushiki Kaisha | Indole derivatives and mono- and diazaindole derivatives |
| DK1032575T3 (da) | 1997-09-05 | 2003-10-20 | Glaxo Group Ltd | 2,3-diaryl-pyrazol(1,5-b)pyridazinderivater, deres fremstilling og anvendelse som cyclooxygenase 2 (COX-2) inhibitor |
| US6887893B1 (en) | 1997-12-24 | 2005-05-03 | Sankyo Company, Limited | Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia |
| SA99191255B1 (ar) | 1998-11-30 | 2006-11-25 | جي دي سيرل اند كو | مركبات سيليكوكسيب celecoxib |
| CA2398995C (en) | 2000-02-04 | 2014-09-23 | Children's Hospital Research Foundation | Lipid hydrolysis therapy for atherosclerosis and related diseases |
| US6465509B2 (en) | 2000-06-30 | 2002-10-15 | Merck Frosst Canada & Co. | Pyrones as inhibitors of cyclooxygenase-2 |
| DE10133665A1 (de) * | 2001-07-11 | 2003-01-30 | Boehringer Ingelheim Pharma | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung |
| CA2484897C (en) | 2002-05-09 | 2015-10-06 | The Brigham And Women's Hospital, Inc. | Soluble st2 as a cardiovascular disease marker and therapeutic target |
| JP2006501179A (ja) | 2002-06-27 | 2006-01-12 | ニトロメッド インコーポレーティッド | シクロオキシゲナーゼ−２選択的阻害剤、組成物、および使用方法 |
| CA2536622C (en) | 2003-08-29 | 2014-02-11 | The Brigham And Women's Hospital, Inc. | Inhibitors of cellular necrosis |
| KR20050051729A (ko) * | 2003-11-28 | 2005-06-02 | 일양약품주식회사 | 사이클로 옥시게나제-2 억제제인 페닐 헤테로사이클의제조방법 |
| DE102004027912A1 (de) * | 2004-06-09 | 2005-12-29 | Grünenthal GmbH | Substituierte Cyclopenten-Verbindungen |
| CA2624601C (en) | 2004-10-06 | 2018-07-03 | The Brigham And Women's Hospital, Inc. | Relevance of achieved levels of markers of systemic inflammation following treatment |
| US7521435B2 (en) | 2005-02-18 | 2009-04-21 | Pharma Diagnostics, N.V. | Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same |
| EP2808015A1 (en) | 2005-05-31 | 2014-12-03 | Mylan Laboratories, Inc | Compositions comprising nebivolol |
| US8119358B2 (en) | 2005-10-11 | 2012-02-21 | Tethys Bioscience, Inc. | Diabetes-related biomarkers and methods of use thereof |
| ES2895078T3 (es) | 2006-03-15 | 2022-02-17 | Brigham & Womens Hospital Inc | Uso de gelsolina para diagnosticar y tratar enfermedades inflamatorias |
| EP2924440A3 (en) | 2006-06-07 | 2016-03-09 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
| CA2684308A1 (en) | 2007-04-18 | 2008-10-30 | Tethys Bioscience, Inc. | Diabetes-related biomarkers and methods of use thereof |
| GB2460915B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| CN103037829A (zh) | 2010-02-01 | 2013-04-10 | 儿童医院 | 用于治疗和预防再狭窄的远程缺血调节 |
| CA2795053A1 (en) | 2010-03-31 | 2011-10-06 | The Hospital For Sick Children | Use of remote ischemic conditioning to improve outcome after myocardial infarction |
| CA2873214C (en) | 2012-05-11 | 2021-02-16 | Reset Therapeutics, Inc. | Carbazole-containing sulfonamides as cryptochrome modulators |
| WO2014145022A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Hybrid necroptosis inhibitors |
| TWI690521B (zh) | 2014-04-07 | 2020-04-11 | 美商同步製藥公司 | 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類 |
| CN112996854B (zh) | 2018-09-19 | 2024-08-30 | 摩登纳特斯有限公司 | 高纯度peg脂质和其用途 |
| MA53650A (fr) | 2018-09-19 | 2021-07-28 | Modernatx Inc | Lipides peg et leurs utilisations |
| CA3119728A1 (en) | 2018-11-21 | 2020-05-28 | Tremeau Pharmaceuticals, Inc. | Purified forms of rofecoxib, methods of manufacture and use |
| US10945992B1 (en) | 2019-11-13 | 2021-03-16 | Tremeau Pharmaceuticals, Inc. | Dosage forms of rofecoxib and related methods |
| US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2012716A1 (en) * | 1989-03-22 | 1990-09-22 | Akito Tanaka | Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same |
| EP0524979A4 (en) * | 1990-04-17 | 1993-03-10 | Allergan, Inc. | 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
| GB9012936D0 (en) * | 1990-06-11 | 1990-08-01 | Fujisawa Pharmaceutical Co | Thiophene derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
| DE9422447U1 (de) * | 1993-01-15 | 2002-10-17 | G.D. Searle LLC, Chicago, Ill. | 3,4-Diarylthiophene und Analoga davon, sowie deren Verwendung als entzündungshemmende Mittel |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| KR960703901A (ko) * | 1993-08-19 | 1996-08-31 | 로즈 암스트롱 | 치환된 2(5H)푸라논, 2(5H)티오페논 및 2(5H)피롤론 유도체, 그의 제조 방법 및 엔도텔린 길항제로서의 그의 용도(Substituted 2(5H)Furanone, 2(5H)Thiophenone and 2(5H)Pyrrolone Derivatives, Their Preparation and Their Use as Endothelin antagonists) |
-
1994
- 1994-12-19 CN CN94195045A patent/CN1143365A/zh active Pending
- 1994-12-19 HU HU9601875A patent/HUT74986A/hu not_active Application Discontinuation
- 1994-12-19 BR BR9408478A patent/BR9408478A/pt not_active Application Discontinuation
- 1994-12-19 AU AU12694/95A patent/AU1269495A/en not_active Abandoned
- 1994-12-19 WO PCT/CA1994/000688 patent/WO1995018799A1/en not_active Ceased
- 1994-12-19 CA CA002180651A patent/CA2180651A1/en not_active Abandoned
- 1994-12-19 JP JP7518234A patent/JP2788677B2/ja not_active Expired - Fee Related
- 1994-12-19 SG SG1996002006A patent/SG43841A1/en unknown
- 1994-12-19 EP EP95903727A patent/EP0739340A1/en not_active Withdrawn
-
1996
- 1996-01-30 NO NO960393A patent/NO960393L/no not_active Application Discontinuation
- 1996-02-12 BG BG100350A patent/BG63082B1/bg unknown
- 1996-07-09 FI FI962800A patent/FI108792B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT74986A (en) | 1997-03-28 |
| BG63082B1 (bg) | 2001-03-30 |
| CN1143365A (zh) | 1997-02-19 |
| CA2180651A1 (en) | 1995-07-13 |
| EP0739340A1 (en) | 1996-10-30 |
| WO1995018799A1 (en) | 1995-07-13 |
| AU1269495A (en) | 1995-08-01 |
| NO960393L (no) | 1996-07-09 |
| JPH09506631A (ja) | 1997-06-30 |
| BG100350A (bg) | 1996-12-31 |
| HU9601875D0 (en) | 1996-09-30 |
| FI108792B (fi) | 2002-03-28 |
| BR9408478A (pt) | 1997-08-26 |
| FI962800L (fi) | 1996-09-06 |
| SG43841A1 (en) | 1997-11-14 |
| FI962800A0 (fi) | 1996-07-09 |
| JP2788677B2 (ja) | 1998-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962800A0 (fi) | Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina | |
| DK1001934T3 (da) | Indolforbindelser som COX-2-inhibitorer | |
| FI965126A7 (fi) | Tri-substituoidut PDE IV -inhibiittoreina hyödylliset fenyylijohdannaiset | |
| IS2027B (is) | Ný spíróasabísýklísk heterósýklísk efnasambönd | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| DK0925287T3 (da) | Heterocykliske metalloproteaseinhibitorer | |
| ATE226573T1 (de) | Heterozyklische metalloproteaseinhibitoren | |
| FI962749L (fi) | Uusia heterosyklisiä yhdisteitä | |
| DK1100797T3 (da) | Heterocycliske forbindelser som inhibitorer af rotamaseenzymer | |
| EE9900259A (et) | Ühendi uus vorm | |
| FI971104A0 (fi) | Menetelmä COX-inhibiittoreina käyttökelpoisten fenyyliheterosyklien valmistamiseksi | |
| DE69906311D1 (de) | Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren | |
| NO992725D0 (no) | 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer | |
| DK1027332T3 (da) | Hidtil ukendte lactametalloproteaseinhibitorer | |
| PT907650E (pt) | N-¬4-(heteroarilmetil)fenil|heteroarilaminasc | |
| DK1060178T3 (da) | Heterocyklisk forbindelser som inhibitorer af rotamase enzymer | |
| FI990922L (fi) | Uusia yhdisteitä | |
| DK1104422T3 (da) | Phenylxanthinderivater | |
| DK0820451T3 (da) | Hidtil ukendte heterocykliske forbindelser | |
| ATE252547T1 (de) | Matrixmetalloproteinaseinhibitoren | |
| DK0944601T3 (da) | Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister | |
| NO993161L (no) | Cyklooksygenaseinhibitor | |
| FI963509A0 (fi) | Isoksatsoliiniyhdisteitä 5-lipoksigenaasi-inhibiittoreina | |
| FI941265A7 (fi) | Heterosyklisiä sulfoniamidotrombiini-inhibiittoreita | |
| ID18481A (id) | 2-(3,5-difluorofenil)-3-(4-metilsulfonil)fenil)-2-siklopenten-1-on yang berguna sebagai inhibitor cox-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |